The role of ATR in preventing age-related diseases

ATR 在预防年龄相关疾病中的作用

基本信息

  • 批准号:
    7907272
  • 负责人:
  • 金额:
    $ 13.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-15 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A gradual loss of genomic integrity has long been proposed to contribute to the aging process. Consistent with this theory, mutation of genes involved in maintaining genome integrity often leads to premature aging. Identifying the potential genetic predispositions to age-related diseases and, more importantly, understanding how these genetic determinants lead to disease will likely guide our ability to better predict, diagnose and slow the onset of these disorders. The ATR protein kinase maintains genome integrity in mammalian cells and is a central regulator of cell cycle checkpoints. Using a cre/lox system that allows conditional deletion of the ATR gene in 2-3 month old adult mice, our preliminary work has demonstrated that several age-related phenotypes appear 3-6 months after ATR deletion. These aging phenotypes include alopecia, hair graying, kyphosis, osteoporosis, cardiomyopathy, testicular atrophy and acute immune suppression. With this unique mouse model, we propose herein to substantiate these initial findings and further explore the role of ATR in preventing age-related diseases. Experiments are proposed to further explore the effect of ATR loss on several disorders that are components of human aging (hair loss and graying, osteoporosis and reduced hematopoietic regenerative capacity) and, importantly, to address if these phenotypes are caused by a loss of regenerative capacity following ATR deletion and/or a direct effect on differentiated cells. To determine if activation of the p53 transcription factor plays a causative role in age-related phenotypes that result from ATR deletion, the premature aging observed in ATR mice will be compared with that observed in mice that lack both ATR and p53. Finally, experiments are proposed that will determine whether the oxidative DNA base damage that results from normal metabolic processes is exacerbated by ATR loss, leading to highly toxic DNA double strand breaks. Such amplification of DNA damage may accelerate normal aging. To test this hypothesis, oxidative DNA damage will be reduced or increased by treatments that modulate intracellular hydroxyl radical concentrations in ATR knockout cells, and the effect of these treatments will be monitored by chromosome spread analysis. These studies will seek a molecular understanding of how ATR deletion leads to premature aging.
描述(由申请人提供):长期以来,人们一直认为基因组完整性的逐渐丧失会导致衰老过程。与这一理论一致,参与维持基因组完整性的基因突变通常会导致过早衰老。识别与年龄相关的疾病的潜在遗传倾向,更重要的是,了解这些遗传决定因素如何导致疾病,可能会指导我们更好地预测、诊断和减缓这些疾病的发作。 ATR 蛋白激酶维持哺乳动物细胞中的基因组完整性,是细胞周期检查点的中央调节器。使用允许在 2-3 个月大的成年小鼠中条件性删除 ATR 基因的 cre/lox 系统,我们的初步工作表明,在 ATR 删除后 3-6 个月出现了几种与年龄相关的表型。这些衰老表型包括脱发、头发花白、脊柱后凸、骨质疏松、心肌病、睾丸萎缩和急性免疫抑制。通过这种独特的小鼠模型,我们在此提出证实这些初步发现并进一步探索 ATR 在预防与年龄相关的疾病中的作用。建议进行实验以进一步探讨 ATR 丧失对人类衰老的几种疾病(脱发和白发、骨质疏松症和造血再生能力降低)的影响,更重要的是,解决这些表型是否是由再生能力丧失引起的ATR 缺失和/或对分化细胞的直接影响后。为了确定 p53 转录因子的激活是否在 ATR 缺失导致的年龄相关表型中起因果作用,我们将在 ATR 小鼠中观察到的过早衰老与在同时缺乏 ATR 和 p53 的小鼠中观察到的过早衰老进行比较。最后,提出了实验来确定正常代谢过程引起的氧化性 DNA 碱基损伤是否会因 ATR 损失而加剧,从而导致剧毒的 DNA 双链断裂。这种 DNA 损伤的放大可能会加速正常衰老。为了检验这一假设,通过调节 ATR 敲除细胞内羟自由基浓度的治疗,可以减少或增加氧化性 DNA 损伤,并且通过染色体扩散分析来监测这些治疗的效果。这些研究将寻求从分子角度理解 ATR 缺失如何导致过早衰老。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric J Brown其他文献

Eric J Brown的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric J Brown', 18)}}的其他基金

Development of a first-in-class combination of DNA damage response inhibitors for the treatment of high-grade serous ovarian cancer
开发用于治疗高级别浆液性卵巢癌的一流 DNA 损伤反应抑制剂组合
  • 批准号:
    10603092
  • 财政年份:
    2023
  • 资助金额:
    $ 13.08万
  • 项目类别:
Effect of DNA repeat silencing on efficacy of ATRi in prostate cancer treatment
DNA重复序列沉默对ATRi治疗前列腺癌疗效的影响
  • 批准号:
    10658509
  • 财政年份:
    2023
  • 资助金额:
    $ 13.08万
  • 项目类别:
A novel protein quality control system and its role in tumorigenesis
一种新型蛋白质质量控​​制系统及其在肿瘤发生中的作用
  • 批准号:
    10088426
  • 财政年份:
    2020
  • 资助金额:
    $ 13.08万
  • 项目类别:
Role of Daxx in protein folding and tumorigenesis
Daxx 在蛋白质折叠和肿瘤发生中的作用
  • 批准号:
    10249990
  • 财政年份:
    2019
  • 资助金额:
    $ 13.08万
  • 项目类别:
Highly specific ATR inhibitors for the targeted treatment of a broad spectrum of cancers
高度特异性的 ATR 抑制剂,用于多种癌症的靶向治疗
  • 批准号:
    9202326
  • 财政年份:
    2016
  • 资助金额:
    $ 13.08万
  • 项目类别:
Effects of ATR-CHK1 inhibition on genome stability and cancer progression
ATR-CHK1 抑制对基因组稳定性和癌症进展的影响
  • 批准号:
    9042322
  • 财政年份:
    2015
  • 资助金额:
    $ 13.08万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    8677675
  • 财政年份:
    2006
  • 资助金额:
    $ 13.08万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    8236593
  • 财政年份:
    2006
  • 资助金额:
    $ 13.08万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    8336944
  • 财政年份:
    2006
  • 资助金额:
    $ 13.08万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    8539204
  • 财政年份:
    2006
  • 资助金额:
    $ 13.08万
  • 项目类别:

相似海外基金

Protein Phosphatase PP2A and DNA damage in cell fate decisions of acute myeloid leukemic cells
蛋白磷酸酶 PP2A 和 DNA 损伤在急性髓系白血病细胞命运决定中的作用
  • 批准号:
    10019487
  • 财政年份:
    2019
  • 资助金额:
    $ 13.08万
  • 项目类别:
Highly specific ATR inhibitors for the targeted treatment of a broad spectrum of cancers
高度特异性的 ATR 抑制剂,用于多种癌症的靶向治疗
  • 批准号:
    9202326
  • 财政年份:
    2016
  • 资助金额:
    $ 13.08万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    7456340
  • 财政年份:
    2006
  • 资助金额:
    $ 13.08万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    7632093
  • 财政年份:
    2006
  • 资助金额:
    $ 13.08万
  • 项目类别:
The role of ATR in preventing age-related diseases
ATR 在预防年龄相关疾病中的作用
  • 批准号:
    7882276
  • 财政年份:
    2006
  • 资助金额:
    $ 13.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了